Korean Journal of Biological Psychiatry (생물정신의학)

The Korean Society of Biological Psychiatry (대한생물정신의학회)
권호 표지

Beyond the SSRIs

SSRIs 이후의 항우울제

  • Lee, Min Soo (Department of Neuropsychiatry, College of Medicine, Korea University) ;
  • Nam, Jong Won (Department of Neuropsychiatry, College of Medicine, Korea University)
  • 이민수 (고려대학교 의과대학 신경정신과학교실) ;
  • 남종원 (고려대학교 의과대학 신경정신과학교실)
  • Published : 1999.06.25
Download PDF
⟨ Previous Next ⟩

Abstract

New antidepressants have become available for clinical use in the 1990s. Before this decade, the drugs available to treat depression consisted essentially of monoamine oxidase inhibitors, tricyclic antidepressants, and lithium. Following the introduction of SSRIs, the options have expanded and now include SSRIs, nefazodone, venlafaxine, mirtazapine, reboxetine, tianeptine. Newer antidepressants possess a variety of pharmacological characteristics that are relevant to the choice of an antidepressant for clinical use. This review summarizes some of the major pharmacological characteristics among the drugs.

Keywords